SILKink Partners

Collaboration

Meet SILKink's team

The SILKink project is led by the University of Pavia in Italy, collaborating with CELLINK Bioprinting.

Partner Catalyze Group will lend its commercial expertise to develop an optimal market access strategy for SILKink.

Universita di Pavia

Cell biology & bone marrow modeling

Bone marrow stem biology
In vitro bone marrow models
Bone marrow diseases
Bioengineering

CELLINK

3D Bioprinting

3D bioprinting solutions to enable critical breakthroughs, ex. 3D cell culture
Drug development

Catalyze

Business development

Strategic and business analysis
Efficient problem solving
Long term strategy

Other projects

Affiliated projects

The SILKink project was developed during the FET Open project SilkFUSION and University of Pavia and CELLINK co-own the background IP.

SilkPlatelet

The SilkPlatelet project is introducing a new technology for the ex vivo production of platelets. The system comprises a bioreactor that mimics the bone marrow niche and allows the differentiation of haematopoietic stem cells into megakaryocyte precursors.

SilkFusion

The primary goal of SilkFUSION is to engineer groundbreaking 3D nanotechnologies for large-scale production of blood platelets for human transfusion from human pluripotent stem cells (hPSCs). Our hypothesis is that platelet production ex-vivo can be optimized by providing megakaryocytes with the correct physical and biochemical environment.